Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Bluett

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Current Rheumatology Reports|April 26, 2012
What have genome-wide studies told us about psoriatic arthritis?James Bluett, Anne Barton
Rheumatic Diseases Clinics of North America|July 17, 2017
Precision Medicine in Rheumatoid ArthritisJames Bluett, Anne Barton
Pharmacogenomics|December 19, 2019
Pharmacogenetics of methotrexate response in rheumatoid arthritis: an updateStephanie F Ling, James Bluett
Open Access Rheumatology : Research and Reviews|May 23, 2024
Towards Personalized Medicine in Rheumatoid ArthritisSeema D Sharma, James Bluett
The Journal of Rheumatology|July 1, 2026
Rethinking Anti-CD20 Therapies: From Fixed to Precision DosingDenis Mulleman, Katarina Vučićević, James Bluett
Expert Review of Clinical Immunology|April 19, 2018
Prediction of response to methotrexate in rheumatoid arthritisStephanie Ling, James Bluett, Anne Barton
Neuropsychiatric Disease and Treatment|July 11, 2024
The Effect of Depression on Disease Activity and Treatment Response in Patients with Inflammatory Arthritis: Results from a Narrative Literature ReviewArav Dagli, Rebecca R Lee, James Bluett
The Journal of Rheumatology|September 3, 2013
Cervical spine calcinosis in systemic sclerosisJames Bluett, Chris Davies, Jonathon Harris, et al.
Rheumatology and Therapy|August 16, 2017
Practical Management of Respiratory Comorbidities in Patients with Rheumatoid ArthritisJames Bluett, Meghna Jani, Deborah P M Symmons
Clinical Chemistry and Laboratory Medicine|August 3, 2023
A sensitive LC-MS/MS methotrexate assay capable of assessing adherence to methotrexate therapy in rheumatoid arthritisMalcolm P McTaggart, James Bluett, Brian G Keevil
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Rheumatology Reports|April 26, 2012
What have genome-wide studies told us about psoriatic arthritis?James Bluett, Anne Barton
Rheumatic Diseases Clinics of North America|July 17, 2017
Precision Medicine in Rheumatoid ArthritisJames Bluett, Anne Barton
Pharmacogenomics|December 19, 2019
Pharmacogenetics of methotrexate response in rheumatoid arthritis: an updateStephanie F Ling, James Bluett
Open Access Rheumatology : Research and Reviews|May 23, 2024
Towards Personalized Medicine in Rheumatoid ArthritisSeema D Sharma, James Bluett
The Journal of Rheumatology|July 1, 2026
Rethinking Anti-CD20 Therapies: From Fixed to Precision DosingDenis Mulleman, Katarina Vučićević, James Bluett
Expert Review of Clinical Immunology|April 19, 2018
Prediction of response to methotrexate in rheumatoid arthritisStephanie Ling, James Bluett, Anne Barton
Neuropsychiatric Disease and Treatment|July 11, 2024
The Effect of Depression on Disease Activity and Treatment Response in Patients with Inflammatory Arthritis: Results from a Narrative Literature ReviewArav Dagli, Rebecca R Lee, James Bluett
The Journal of Rheumatology|September 3, 2013
Cervical spine calcinosis in systemic sclerosisJames Bluett, Chris Davies, Jonathon Harris, et al.
Rheumatology and Therapy|August 16, 2017
Practical Management of Respiratory Comorbidities in Patients with Rheumatoid ArthritisJames Bluett, Meghna Jani, Deborah P M Symmons
Clinical Chemistry and Laboratory Medicine|August 3, 2023
A sensitive LC-MS/MS methotrexate assay capable of assessing adherence to methotrexate therapy in rheumatoid arthritisMalcolm P McTaggart, James Bluett, Brian G Keevil
Pageof 5